On Dec. 8, 1999, the National Cancer Institute published the Atlas of Cancer Mortality, 1950-94, showing the geographic…
On Dec. 2, 1999, Alvin and Ruth Siteman donated $35 million to establish the Alvin J. Siteman Cancer…
On Nov. 23, 199, the National Cancer Institute awarded nearly $8 million in grants toward the creation of…
On Jun. 7 1999, NeoPath merged with AutoCyte to form TriPath Imaging based in Burlington, N.C. NeoPath was…
On Mar. 17, 1999, the Hybrid Capture II human papillomavirus (HPV) DNA test was approved by the U.S….
In 1999, The Indiana University (IU) Cancer Center became an National Cancer Institute (NCI)-designated cancer center. Its mission…
In 1999, the Hudson-Webber Cancer Research Center opened to serve as a ‘translational’ research facility, bridging the gaps…
In 1999, Timothy J. Eberlein, MD was named director of the Alvin J. Siteman Cancer Center. As director…
In 1999, Washington University – St. Louis radiation oncologists were instrumental in developing the world’s first big bore…
In 1999, the Eppley Cancer Center became a National Cancer Institute (NCI) designated cancer center. NCI grant funding…
In 1999, American Association for Cancer Research (AACR) Scientist-Survivor Program which united researchers with patients and survivor advocates…
In 1999, the Vancouver Prostate Centre received a $20 million donation by Vancouver businessman Jim Pattison, the largest…
In 1999, Michael Smith, recipient of the 1993 Nobel Prize in Chemistry, founded Canada’s Michael Smith Genome Science…
In 1999, Trubion Pharmaceutical was founded in Seattle as a spin-off from the Pacific Northwest Diabetes Research Institute,…
On Dec. 22, 1998, Washington University – St. Louis researcher Jeffrey I. Gordon, MD and colleagues developed a…
On Sept. 8, 1998, the Medical College of Georgia researchers Dr. David Munn and immunologist Andrew Melllor identified…
On Jun. 16, 1998, University of Washington Medicine, Fred Hutchinson Cancer Research Center and Seattle Children’s announced the…
On April 30, 1998, the Food and Drug Administration (FDA) approved the Genentech’s drug Xeloda (capecitabine) for the…
On Jan. 13, 1998, Seattle Genetics (Seagen) was founded in Bothell as a biotechnology company focused on developing…
In 1998, National Cancer Institute (NCI)Â awarded the City of Hope Cancer Center NCI-comprehensive cancer center designation. City…
In 1998, The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee which…
In 1998, University of Calgary’s Dr. Patrick Lee revealed that reovirus injected in mice shrank tumours from brain…
In 1998, Cancer incidence rates showed first sustained decline since the National Cancer Institute (NCI) began keeping records…
In 1998, Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some…
In 1998, Tamoxifen, created with the MCF-7 breast cancer cell line established by Karmanos, was revealed to reduce…
In 1998, The Case Cancer Center (Case CCC) was recognized as an National Cancer Institute (NCI)-designated comprehensive cancer…
In 1998, the Centers for Disease Control and Prevention (CDC) reported that an estimated 47.2 million adults (24.1%),…
On Nov. 6, 1997, the National Cancer Institute Director’s Consumer Liaison Group was established to advise and provide…
In 1997, the Cancer Genome Anatomy Project (CGAP), created by the National Cancer Institute (NCI), is a multi-year…
In 1997, the the University of California, Irvine (UCI) Chao Family Comprehensive Cancer Center (CFCCC) gained NCI designated…